Phase I Dose Escalation Study with Expansion Cohort of the Addition of Nab-Paclitaxel to Capecitabine and Oxaliplatin (CapOx) as First-Line Treatment of Metastatic Esophagogastric Adenocarcinoma (ACTION Study).
在转移性食管胃腺癌的一线治疗中，将纳米白蛋白紫杉醇添加到卡培他滨和奥沙利铂（CapOx）中，进行 I 期剂量递增研究及扩展队列研究（ACTION 研究）
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers11060827
Schokker Sandor, van der Woude Stephanie O, van Kleef Jessy Joy, van Zoen Daan J, van Oijen Martijn G H, Mearadji Banafsche, Beenen Ludo F M, Stroes Charlotte I, Waasdorp Cynthia, Jibodh R Aarti, Creemers Aafke, Meijer Sybren L, Hooijer Gerrit K J, Punt Cornelis J A, Bijlsma Maarten F, van Laarhoven Hanneke W M
